ArticleScientific reports2019
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program.
Vincenza Calvaruso et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it